NLRP3 and Parkinson disease: It was recently shown that miR‐30e improves neuronal damage, neuroinflammation and dyskinesia via targeting Nlrp3 expression and inhibiting NLRP3 inflammasome activation in a MPTP‐induced PD mice model 152.